Eloxx Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2017	2016	2015	2014	2013 - 1997
Cash & Equivalents	19.21	42.27	24.67	22.49	48.61	24.05	0.03	0.81	3.33	6.11	Upgrade
Short-Term Investments	0	0	0	33.78	0	0	0	0	0	0	Upgrade
Cash & Cash Equivalents	19.21	42.27	24.67	56.28	48.61	24.05	0.03	0.81	3.33	6.11	Upgrade
Cash Growth	-54.56%	71.35%	-56.17%	15.78%	102.11%	72341.11%	-95.91%	-75.69%	-45.44%	281.41%	Upgrade
Receivables	0	0	0	0.03	0	0	0	0	0	0.04	Upgrade
Inventory	0	0	0	0.71	0	0	0	0	0	0	Upgrade
Other Current Assets	0.92	1.21	1.23	0.7	1.74	0.46	0.25	0.17	0.4	1.07	Upgrade
Total Current Assets	20.13	43.48	25.89	57.71	50.34	24.51	0.28	0.98	3.73	7.22	Upgrade
Property, Plant & Equipment	0.99	1.66	0.55	1.13	0.25	0.28	0.05	0.09	0.19	0.22	Upgrade
Goodwill	0	0	0	0	0	0	0	0	5.78	13.9	Upgrade
Intangible Assets	0	0	0	0	0	0	5.5	8.1	9.8	11.98	Upgrade
Other Long-Term Assets	0	0	0.03	0.11	0.13	0	0.01	0.05	0.05	0.01	Upgrade
Total Long-Term Assets	0.99	1.66	0.58	1.24	0.38	0.28	5.56	8.24	15.82	26.11	Upgrade
Total Assets	21.12	45.14	26.48	58.95	50.72	24.78	5.85	9.23	19.55	33.33	Upgrade
Accounts Payable	3.02	1.38	0.48	1.87	0.75	1.53	0.19	0.09	0.23	0.9	Upgrade
Deferred Revenue	12.54	3.72	0.81	0.4	0	0	0.33	0	0	0	Upgrade
Current Debt	4.69	0.66	5.63	4.84	0	0	0.41	0	0	0	Upgrade
Other Current Liabilities	2.84	4.2	2.92	4.7	7.06	1.89	1.84	0.28	0.55	0.92	Upgrade
Total Current Liabilities	23.09	9.96	9.84	11.81	7.81	3.42	2.77	0.37	0.78	1.83	Upgrade
Long-Term Debt	8.69	12.8	6.41	10.93	0	0	0	0	0	0	Upgrade
Other Long-Term Liabilities	0	0	0	0	0	0	2.2	4.3	6.54	4.02	Upgrade
Total Long-Term Liabilities	8.69	12.8	6.41	10.93	0	0	2.2	4.3	6.54	4.02	Upgrade
Total Liabilities	31.78	22.76	16.25	22.73	7.81	3.42	4.97	4.67	7.32	5.84	Upgrade
Total Debt	13.38	13.46	12.04	15.76	0	0	0.41	0	0	0	Upgrade
Debt Growth	-0.54%	11.80%	-23.63%	-	-	-	-	-	-	-	Upgrade
Common Stock	0.02	0.02	0.4	0.4	0.36	0.27	0.29	0.2	0.19	0.14	Upgrade
Retained Earnings	-274.39	-238.32	-171.6	-137.02	-86.15	-38.96	-121.82	-115.63	-107.18	-88.28	Upgrade
Comprehensive Income	0	0	0	0.02	0	0	0	0	0	0	Upgrade
Shareholders' Equity	-10.66	22.38	10.23	36.21	42.91	21.36	0.87	4.56	12.22	27.49	Upgrade
Total Liabilities and Equity	21.12	45.14	26.48	58.95	50.72	24.78	5.85	9.23	19.55	33.33	Upgrade
Net Cash / Debt	5.82	28.81	12.63	40.51	48.61	24.05	-0.37	0.81	3.33	6.11	Upgrade
Net Cash / Debt Growth	-79.79%	128.10%	-68.82%	-16.65%	102.11%	-	-	-75.69%	-45.44%	-	Upgrade
Net Cash Per Share	2.69	16.47	12.59	42.58	59.94	193.31	-12.88	31.92	185.04	892.82	Upgrade
Working Capital	-2.96	33.53	16.06	45.9	42.53	21.08	-2.49	0.61	2.95	5.4	Upgrade
Book Value Per Share	-4.92	12.80	10.20	38.06	52.92	171.70	30.02	179.53	678.36	4016.06	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.